Antares Pharma reported $48.73M in Sales Revenues for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US $ 11257M 638M
Abbvie ABBV:US $ 14583M 1045M
Adma Biologics ADMA:US $ 29.1M 2.72M
Aerie Pharmaceuticals AERI:US $ 33.31M 3.48M
Ani Pharmaceuticals ANIP:US $ 73.86M 9.38M
Atrion ATRI:US 48.88M 8.59M
Becton, Dickinson and BDX:US $ 4641M 370M
Cara Therapeutics CARA:US $ 23M 18.21M
Cerus CERS:US $ 47.63M 4.61M
Eli Lilly And LLY:US $ 6488M 1322M
Horizon Pharma HZNP:US $ 876.41M 8.83M
JAZZ PHA JAZZ:US $ 932.88M 119.16M
Meridian Bioscience VIVO:US $ 67.77M 43.46M
Orasure Technologies OSUR:US $ 160.46M 92.76M
Pacira Pharmaceuticals PCRX:US $ 169.41M 11.42M
Pfizer PFE:US $ 27742M 2081M
Revance Therapeutics RVNC:US $ 28.37M 3.11M
Sientra SIEN:US $ 21.4M 1.25M
Staar Surgical STAA:US $ 63.2M 4.2M
Supernus Pharmaceuticals SUPN:US $ 170.05M 17.55M
Teva Pharmaceutical TEVA:IT 3.79B 125M
Teva Pharmaceutical Industries TEVA:US $ 3786M 125M
Utah Medical Products UTMD:US $ 13.43M 856K